IP Verse

Topical Localized Isoxazoline Formulation - EP2658542B1

PatentPatent Analysis

EP2658542

INTERVET
Application Number
EP11813330A
Filing Date
Dec 22, 2011
Status
Granted And Under Opposition
Dec 24, 2021
Grant Date
Jan 26, 2022
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP2833866B2
EP3707128B1
EP4153133B1

Bibliography

The patent EP2658542B1 was granted to Intervet on Jan 26, 2022 following the initial filing on Dec 22, 2011 under the application number EP11813330A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

VIRBACOct 25, 2022ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents